Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors
Authors
Keywords
-
Journal
Cell and Bioscience
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-06
DOI
10.1186/s13578-021-00720-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CLpro Inhibitors
- (2021) Jonathan M. O. Rawson et al. Viruses-Basel
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
- (2021) Chunlong Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
- (2021) Jingxin Qiao et al. SCIENCE
- Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
- (2021) Zinuo Chen et al. Cell and Bioscience
- Fluorescence polarization system for rapid COVID-19 diagnosis
- (2021) Chang Yeol Lee et al. BIOSENSORS & BIOELECTRONICS
- Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study
- (2021) Mohammad Aatif et al. Marine Drugs
- Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro
- (2021) Ruikun Du et al. ANTIVIRAL RESEARCH
- An all-out assault on SARS-CoV-2 replication
- (2021) Ronald T. Hay BIOCHEMICAL JOURNAL
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2: from its discovery to genome structure, transcription, and replication
- (2021) Ayslan Castro Brant et al. Cell and Bioscience
- Dieckol: a brown algal phlorotannin with biological potential
- (2021) Durairaj Karthick Rajan et al. BIOMEDICINE & PHARMACOTHERAPY
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
- (2020) Bhupesh Goyal et al. ACS Combinatorial Science
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CLpro Reporter Assay
- (2020) Heather M. Froggatt et al. JOURNAL OF VIROLOGY
- Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID ‐19: A review
- (2020) Bikash Adhikari et al. PHYTOTHERAPY RESEARCH
- Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
- (2020) Zhe Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2020) Wayne Vuong et al. Nature Communications
- Covid-19: Remdesivir has little or no impact on survival, WHO trial shows
- (2020) Owen Dyer BMJ-British Medical Journal
- Optimizations of a novel fluorescence polarization-based high-throughput screening assay for β-catenin/LEF1 interaction inhibitors
- (2020) Yunyu Chen et al. ANALYTICAL BIOCHEMISTRY
- Covid-19: What now for remdesivir?
- (2020) Jeremy Hsu BMJ-British Medical Journal
- ACE2: the molecular doorway to SARS-CoV-2
- (2020) Miriam Marlene Medina-Enríquez et al. Cell and Bioscience
- Sensitive Rapid Fluorescence Polarization Immunoassay for Free Mycophenolic Acid Determination in Human Serum and Plasma
- (2018) Bettina Glahn-Martínez et al. ANALYTICAL CHEMISTRY
- Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme
- (2018) Jian Lu et al. PHYTOMEDICINE
- Anti-HIV-1 activity of phlorotannin derivative 8,4‴-dieckol from Korean brown algaEcklonia cava
- (2014) Fatih Karadeniz et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava
- (2013) Ji-Young Park et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Potential pharmacological applications of polyphenolic derivatives from marine brown algae
- (2011) Noel Vinay Thomas et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Influenza Virus Neuraminidase Inhibitory Activity of Phlorotannins from the Edible Brown AlgaEcklonia cava
- (2011) Young Bae Ryu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started